On April 11, the Food and Drug Administration (FDA) issued a notice reminding health care providers about the intended use of radiological computer-aided triage and notification devices for intracranial large vessel occlusion.

On Dec. 9, the American Medical Association (AMA) and American Hospital Association (AHA) filed suit against the Biden Administration to stop part of the surprise billing regulations from going into effect in January.

On Oct. 15, U.S. Department of Health and Human Services Secretary Xavier Becerra renewed the COVID-19 public health emergency (PHE) declaration. Effective Oct. 16, the PHE was extended for an additional 90 days.

The Congress of Neurological Surgeons (CNS)/American Association of Neurological Surgeons (AANS) Washington Committee provides eligible neurosurgical residents and fellows an opportunity for a richer, more diverse and actionable experience in health care policy and advocacy — in both the regulatory and legislative arenas.

As part of the ongoing efforts to provide health care providers with protections from unfounded lawsuits, the Health Coalition on Liability and Access (HCLA) — of which the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS) serve as vice-chair — has joined a chorus of stakeholders in calling on Congress to pass legislation to safeguard medical professionals, and the facilities in which they practice, from COVID-19-related medical liability lawsuits. Examples of increased liability risk that providers are confronting because of COVID-19 include: